HUTCHMED (China) Ltd(HCM)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2025-12-31.

HUTCHMED (China) Ltd (HCM) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores HCM at 51.5/100 on a 32-signal composite quality model, placing it at rank #1,521 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (FY 2025), HUTCHMED (China) Ltd reports quarterly revenue of $548.5M, net income of $456.9M, an operating margin of -7.1%. Top institutional holders of HCM by reported 13-F value include SCHRODER INVESTMENT MANAGEMENT GROUP, Allianz Asset Management GmbH, STATE STREET, based on the most recent SEC filings. HCM trades on the Nasdaq exchange and files with the SEC under CIK 1648257. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HCM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for HUTCHMED (China) Ltd directly from SEC EDGAR.